In the BioHarmony Drug Report Database
Norpace (disopyramide) is a small molecule pharmaceutical. Disopyramide was first approved as Norpace on 1982-01-01. It is used to treat atrial fibrillation, atrial flutter, cardiac arrhythmias, and ventricular premature complexes in the USA. It is known to target potassium voltage-gated channel subfamily H member 2 and alpha-1-acid glycoprotein 2.
Image (chem structure or protein)